Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Consensus and Guidelines · February 03, 2022

Decisions With Patients and Families Regarding Aducanumab for Alzheimer Disease



Additional Info

Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement
Neurology 2021 Nov 17;[EPub Ahead of Print], W Chiong, BD Tolchin, RJ Bonnie, K Busl, S Cruz-Flores, LG Epstein, EP Greene, J Illes, M Kirschen, DG Larriviere, S Mantri, MA Rubin, BJ Stern, LP Taylor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading